IP Library Granted Patent US 7,655,621
Granted Patent B2
US 7,655,621 · App. 11/895,555 · Granted Feb 2, 2010

Cross-linked glycopeptide-cephalosporin antibiotics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,621
App. No.
11/895,555
Granted
Feb 2, 2010
Kind
B2
Abstract

This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.

Claims (19)

1. A lyophilized composition comprising:

(a) a therapeutically effective amount of a compound of the formula:

or a pharmaceutically acceptable salt thereof and

(b) a pharmaceutically-acceptable carrier.

2. The lyophilized composition of claim 1 , wherein the pharmaceutically acceptable carrier is sucrose, mannitol, dextrose, dextran, lactose, or a combination thereof.

3. The lyophilized composition of claim 1 , wherein the pharmaceutically acceptable carrier is sucrose, mannitol, or a combination thereof.

4. The lyophilized composition of claim 1 , wherein the pharmaceutically acceptable carrier is sucrose.

5. The lyophilized composition of claim 1 , wherein the composition is sterile.

6. The lyophilized composition of claim 1 , wherein the compound is a hydrochloride salt.

7. An aqueous composition comprising:

(a) a therapeutically effective amount of a compound of the formula:

or a pharmaceutically acceptable salt thereof

(b) a pharmaceutically-acceptable carrier; and

(c) water.

8. The aqueous composition of claim 7 , wherein the pharmaceutically acceptable carrier is sucrose, mannitol, dextrose, dextran, lactose, or a combination thereof.

9. The aqueous composition of claim 7 , wherein the pharmaceutically acceptable carrier is sucrose, mannitol, or a combination thereof.

10. The aqueous composition of claim 7 , wherein the pharmaceutically acceptable carrier is sucrose.

11. The aqueous composition of claim 7 , wherein the composition is sterile.

12. The aqueous composition of claim 7 , wherein the compound is a hydrochloride salt.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033179/0484 →